STOCK TITAN

[Form 3] Vyome Holdings, Inc Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

John M. Tincoff III filed an initial Form 3 reporting his relationship to Vyome Holdings, Inc. (ticker shown in the filing as HIND) as a Director. The event date is 08/15/2025. The filing states no securities are beneficially owned by the reporting person. The form is signed and dated 09/18/2025.

John M. Tincoff III ha presentato inizialmente un Modulo 3 riferendo il proprio rapporto con Vyome Holdings, Inc. (ticker indicato nel fascicolo come HIND) come Director. La data dell’evento è 15/08/2025. Il fascicolo indica che nessun titolo è posseduto direttamente dall’interessato. Il modulo è stato firmato e datato 18/09/2025.

John M. Tincoff III presentó inicialmente un Formulario 3 informando su relación con Vyome Holdings, Inc. (el ticker que figura en la presentación como HIND) como Director. La fecha del evento es 15/08/2025. El formulario indica que no posee de forma beneficiosa valores por parte del informante. El formulario está firmado y fechado el 18/09/2025.

John M. Tincoff III은 Vyome Holdings, Inc.와의 관계를 Director로 보고하는 최초의 Form 3를 제출했습니다. 사건 날짜는 2025/08/15입니다. 보고서는 보고자에 의해 유익하게 소유된 증권이 없음이라고 명시합니다. 양식은 2025/09/18에 서명되고 날짜가 기재되어 있습니다.

John M. Tincoff III a déposé initialement un Formulaire 3 signalant sa relation avec Vyome Holdings, Inc. (le ticker indiqué dans le dossier comme HIND) en tant que Directeur.La date de l’événement est le 15/08/2025. Le formulaire indique qu’aucun titre n’est déposé au nom du déclarant. Le formulaire est signé et daté du 18/09/2025.

John M. Tincoff III hat zunächst ein Formular 3 eingereicht und darin seine Beziehung zu Vyome Holdings, Inc. (das in der Einreichung als HIND angezeigte Kürzel) als Direktor angegeben. Das Ereignisdatum ist der 15.08.2025. Das Formular gibt an, dass keine Wertpapiere im Besitz der meldenden Person sind. Das Formular ist unterschrieben und datiert am 18.09.2025.

جون م. تينكوف الثالث قدم أولاً نموذج 3 للإبلاغ عن علاقته بـ Vyome Holdings, Inc. (الرمز المدرج في الملف كـ HIND) كـ مدير. تاريخ الحدث هو 15/08/2025. يذكر النموذج أن لا يمتلك أي أوراق مالية بشكل مستفيد من جانب المبلِغ. تم توقيع النموذج وتاريخه في 18/09/2025.

John M. Tincoff III 最初提交了 表格3,报告他与 Vyome Holdings, Inc. 的关系为 董事。事件日期为 2025/08/15。申报表指出 该报告人并未实际直接拥有任何证券。该表格已签名并日期为 2025/09/18

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A director filed an initial ownership statement reporting no beneficial holdings, a routine governance disclosure.

The filing shows John M. Tincoff III as a director of Vyome Holdings, Inc. and contains an initial statement of beneficial ownership with an explicit declaration that no securities are beneficially owned. This indicates the reporting person does not currently hold equity or derivative positions disclosed on Form 3. For corporate governance, such a disclosure is customary when an individual becomes a reporting person or assumes a director role.

TL;DR: Form 3 submitted identifying reporting person and issuer ticker, with no listed holdings.

The document identifies the issuer as Vyome Holdings, Inc. (ticker printed as HIND) and records the event date 08/15/2025. Table sections for non-derivative and derivative securities contain the statement: No securities are beneficially owned. The form is signed 09/18/2025, completing the initial filing requirements reflected in the document.

John M. Tincoff III ha presentato inizialmente un Modulo 3 riferendo il proprio rapporto con Vyome Holdings, Inc. (ticker indicato nel fascicolo come HIND) come Director. La data dell’evento è 15/08/2025. Il fascicolo indica che nessun titolo è posseduto direttamente dall’interessato. Il modulo è stato firmato e datato 18/09/2025.

John M. Tincoff III presentó inicialmente un Formulario 3 informando su relación con Vyome Holdings, Inc. (el ticker que figura en la presentación como HIND) como Director. La fecha del evento es 15/08/2025. El formulario indica que no posee de forma beneficiosa valores por parte del informante. El formulario está firmado y fechado el 18/09/2025.

John M. Tincoff III은 Vyome Holdings, Inc.와의 관계를 Director로 보고하는 최초의 Form 3를 제출했습니다. 사건 날짜는 2025/08/15입니다. 보고서는 보고자에 의해 유익하게 소유된 증권이 없음이라고 명시합니다. 양식은 2025/09/18에 서명되고 날짜가 기재되어 있습니다.

John M. Tincoff III a déposé initialement un Formulaire 3 signalant sa relation avec Vyome Holdings, Inc. (le ticker indiqué dans le dossier comme HIND) en tant que Directeur.La date de l’événement est le 15/08/2025. Le formulaire indique qu’aucun titre n’est déposé au nom du déclarant. Le formulaire est signé et daté du 18/09/2025.

John M. Tincoff III hat zunächst ein Formular 3 eingereicht und darin seine Beziehung zu Vyome Holdings, Inc. (das in der Einreichung als HIND angezeigte Kürzel) als Direktor angegeben. Das Ereignisdatum ist der 15.08.2025. Das Formular gibt an, dass keine Wertpapiere im Besitz der meldenden Person sind. Das Formular ist unterschrieben und datiert am 18.09.2025.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Tincoff John M. III

(Last) (First) (Middle)
HARVARD SQUARE,
ONE MIFFLIN PLACE, SUITE 400

(Street)
CAMBRIDGE MA 02138

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/15/2025
3. Issuer Name and Ticker or Trading Symbol
Vyome Holdings, Inc [ HIND ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ John Tincoff 09/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Reshape Lifesciences Inc.

NASDAQ:RSLS

RSLS Rankings

RSLS Latest News

RSLS Latest SEC Filings

RSLS Stock Data

7.64M
5.48M
10.63%
1.35%
2.19%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN CLEMENTE